Michelle Stephens
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,619 of the $8,085 with a category attached, or 81.9%. It is spread thinly across 40 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 223 payments — averaging $36.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AstraZeneca$686
- Boston Scientific$601
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$449
- Boehringer Ingelheim$431
- Kestra Medical Technology Services, Inc.$426
- plus $4K from 34 others
What the payments were for
- Travel & lodging$1,46618%
- Food & beverage$6,61982%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $1,527 |
| AstraZeneca | 20 | $686 |
| Boston Scientific | 11 | $601 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $449 |
| Boehringer Ingelheim | 12 | $431 |
| Kestra Medical Technology Services, Inc. | 16 | $426 |
| Lexicon Pharmaceuticals, Inc. | 11 | $368 |
| GSK | 13 | $326 |
| Merck | 15 | $290 |
| Grifols USA, LLC | 4 | $238 |
| E.r. Squibb & Sons, L.L.C. | 3 | $238 |
| United Therapeutics Corporation | 4 | $223 |
| Novartis | 10 | $209 |
| Amgen | 11 | $207 |
| Johnson & Johnson | 5 | $202 |
| Cvrx, Inc. | 3 | $144 |
| Insmed, Inc. | 10 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $133 |
| Vifor Pharma, Inc. | 1 | $125 |
| Esperion Therapeutics, Inc. | 6 | $102 |
| Novo Nordisk | 5 | $88 |
| Edwards Lifesciences | 2 | $88 |
| Pfizer | 4 | $87 |
| Baxter Healthcare | 4 | $80 |
| Verona Pharma, Inc. | 3 | $75 |
| Harmony Biosciences LLC | 2 | $72 |
| Smith+Nephew | 1 | $71 |
| Lilly USA, LLC | 3 | $62 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Philips North America LLC | 2 | $47 |
| Abiomed | 2 | $46 |
| Sanofi | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Bayer | 2 | $40 |
| Viatris Specialty LLC | 2 | $33 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $31 |
| Abbott | 1 | $23 |
| Liquidia Technologies, Inc. | 1 | $20 |
| Bard Peripheral Vascular, Inc. | 1 | $15 |
| Shionogi Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaSeal$1,211
- LifeVest$336
- Varithena Administration Pack$280
- FARXIGA$227
- CAMZYOS$222
- Prolastin-C Liquid$158
- WATCHMAN FLX$150
- Assure WCD$135
- Veltassa$125
- NUCALA$125
- Inpefa$124
- JARDIANCE$124
- OFEV$122
How this compares
$8,085 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Other family in Ocala
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.